Arai Eri, Ushijima Saori, Tsuda Hitoshi, Fujimoto Hiroyuki, Hosoda Fumie, Shibata Tatsuhiro, Kondo Tadashi, Imoto Issei, Inazawa Johji, Hirohashi Setsuo, Kanai Yae
Pathology Division, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan.
Clin Cancer Res. 2008 Sep 1;14(17):5531-9. doi: 10.1158/1078-0432.CCR-08-0443.
The aim of this study was to clarify genetic and epigenetic alterations occurring during renal carcinogenesis.
Copy number alterations were examined by array-based comparative genomic hybridization analysis using an array harboring 4,361 bacterial artificial chromosome clones, and DNA methylation alterations on CpG islands of the p16, human MutL homologue 1, von Hippel-Lindau, and thrombospondin 1 genes and the methylated in tumor (MINT-1, MINT-2, MINT-12, MINT-25, and MINT-31) clones were examined in 51 clear cell renal cell carcinomas (RCC).
By unsupervised hierarchical clustering analysis based on copy number alterations, clear cell RCCs were clustered into the two subclasses, clusters A (n=34) and B (n=17). Copy number alterations were accumulated in cluster B. Loss of chromosome 3p and gain of 5q and 7 were frequent in both clusters A and B, whereas loss of 1p, 4, 9, 13q, and 14q was frequent only in cluster B. The average number of methylated CpG islands in cluster B was significantly higher than those in cluster A. Clear cell RCCs showing higher histologic grades, vascular involvement, renal vein tumor thrombi, and higher pathologic stages were accumulated in cluster B. The recurrence-free and overall survival rates of patients in cluster B were significantly lower than those of patients in cluster A. Multivariate analysis revealed that genetic clustering was a predictor of recurrence-free survival and was independent of histologic grade and pathologic stage.
This genetic clustering of clear cell RCC is significantly associated with regional DNA hypermethylation and may become a prognostic indicator for patients with RCC.
本研究旨在阐明肾癌发生过程中出现的基因和表观遗传改变。
使用包含4361个细菌人工染色体克隆的芯片,通过基于芯片的比较基因组杂交分析检测拷贝数改变,并在51例透明细胞肾细胞癌(RCC)中检测p16、人MutL同源物1、冯·希佩尔-林道蛋白和血小板反应蛋白1基因的CpG岛以及肿瘤甲基化(MINT-1、MINT-2、MINT-12、MINT-25和MINT-31)克隆的DNA甲基化改变。
基于拷贝数改变的无监督层次聚类分析显示,透明细胞RCC可分为两个亚类,A组(n = 34)和B组(n = 17)。B组中拷贝数改变更多。3号染色体短臂缺失以及5号染色体长臂和7号染色体增加在A组和B组中均较为常见,而1号染色体短臂、4号、9号、13号染色体长臂和14号染色体长臂缺失仅在B组中较为常见。B组中甲基化CpG岛的平均数量显著高于A组。组织学分级较高、存在血管侵犯、肾静脉瘤栓以及病理分期较高的透明细胞RCC集中在B组。B组患者的无复发生存率和总生存率显著低于A组患者。多因素分析显示,基因聚类是无复发生存的预测指标,且独立于组织学分级和病理分期。
透明细胞RCC的这种基因聚类与区域DNA高甲基化显著相关,可能成为RCC患者的预后指标。